International
From October 1, 2025, the U.S. will impose 100% tariffs on imported branded or patented pharmaceutical products, unless the manufacturers are already building or expanding U.S. facilities. Who Is Most Exposed European pharmaceutical exporters are expected to be the worst affected, especially those exporting high-value branded drugs. India, by contrast, may be less impacted